Topic

JAK Inhibitors

3 articles, newest first.

JAK InhibitorsClinical TrialsAlopecia Areata
Ritlecitinib Changed Everything, But Not For the Reason Most People Think
The FDA approval of ritlecitinib for alopecia areata in 2023 was framed as a win for one autoimmune condition. The researchers who understand where this drug family is going know it's something bigger.
May 16, 2026·5 days ago·Dr. Maya Chen
JAK InhibitorsAlopecia AreataClinical Trials
Baricitinib Two-Year Follow-Up Data: What Actually Happens After the Trial Ends
The FDA approved baricitinib for severe alopecia areata in 2022. Two years later, the open-label extension data answers the question nobody asked in the initial trial: what happens when patients stop taking it?
May 5, 2026·16 days ago·Dr. Maya Chen
Alopecia AreataJAK InhibitorsClinical Trials
Alopecia Areata: Beyond JAK Inhibitors, What Else Is in the Pipeline
JAK inhibitors transformed alopecia areata treatment, but they're not the end of the story. Several other immune-modulating approaches are advancing through clinical trials.
Dec 9, 2025·5 months ago·Dr. Maya Chen

← Browse all topics